Valerie A. LuyckxRenal Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa Department of Nephrology, University Children’s Hospital, Zürich, Switzerland
JagerKJ, KovesdyC, LanghamR, RosenbergM, JhaV, ZoccaliC: A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int96: 1048–1050, 201910.1016/j.kint.2019.07.012
JagerKJ, KovesdyC, LanghamR, RosenbergM, JhaV, ZoccaliC: A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int 96: 1048–1050, 201910.1016/j.kint.2019.07.012)| false
LewingtonAJ, CerdáJ, MehtaRL: Raising awareness of acute kidney injury: A global perspective of a silent killer. Kidney Int84: 457–467, 201310.1038/ki.2013.153PubMed
LewingtonAJ, CerdáJ, MehtaRL: Raising awareness of acute kidney injury: A global perspective of a silent killer. Kidney Int 84: 457–467, 201310.1038/ki.2013.153PubMed)| false
International Society of Nephrology: Global Kidney Health Atlas: A Report by the International Society of Nephrology on the Global Burden of End-Stage Kidney Disease and Capacity for Kidney Replacement Therapy and Conservative Care across World Countries and Regions, Brussels, Belgium, International Society of Nephrology, 2019
International Society of Nephrology: Global Kidney Health Atlas: A Report by the International Society of Nephrology on the Global Burden of End-Stage Kidney Disease and Capacity for Kidney Replacement Therapy and Conservative Care across World Countries and Regions, Brussels, Belgium, International Society of Nephrology, 2019)| false
BikbovB, PericoN, RemuzziG; on behalf of the GBD Genitourinary Diseases Expert Group: Disparities in chronic kidney disease prevalence among males and females in 195 countries: Analysis of the Global Burden of Disease 2016 Study. Nephron139: 313–318, 201810.1159/000489897PubMed
BikbovB, PericoN, RemuzziG; on behalf of the GBD Genitourinary Diseases Expert Group: Disparities in chronic kidney disease prevalence among males and females in 195 countries: Analysis of the Global Burden of Disease 2016 Study. Nephron 139: 313–318, 201810.1159/000489897PubMed)| false
GBD Chronic Kidney Disease Collaboration: Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet395: 709–733, 202010.1016/s0140-6736(20)30045-3PubMed
GBD Chronic Kidney Disease Collaboration: Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395: 709–733, 202010.1016/s0140-6736(20)30045-3PubMed)| false
International Society of Nephrology: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Available at https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf. Accessed April 30, 2021)| false
International Society of Nephrology: Global Kidney Health Atlas: A report by the International Society of Nephrology on the current state of organization and structures for kidney care across the globe. Available at https://www2.theisn.org/GKHA. Accessed April 30, 2021
YeungE, BelloAK, LevinA, LunneyM, OsmanMA, YeF, et al.: Current status of health systems financing and oversight for end-stage kidney disease care: A cross-sectional global survey. BMJ Open11: e047245, 202110.1136/bmjopen-2020-047245PubMed
YeungE, BelloAK, LevinA, LunneyM, OsmanMA, YeF, : Current status of health systems financing and oversight for end-stage kidney disease care: A cross-sectional global survey. BMJ Open 11: e047245, 202110.1136/bmjopen-2020-047245PubMed)| false
BelloAK, LevinA, LunneyM, OsmanMA, YeF, AshuntantangGE, et al.: Status of care for end stage kidney disease in countries and regions worldwide: International cross sectional survey. BMJ367: l5873, 201910.1136/bmj.l5873PubMed
BelloAK, LevinA, LunneyM, OsmanMA, YeF, AshuntantangGE, : Status of care for end stage kidney disease in countries and regions worldwide: International cross sectional survey. BMJ 367: l5873, 201910.1136/bmj.l5873PubMed)| false
LuyckxVA: Ethical Challenges Relating to Provision of Sustainable Renal Care in Resource Limited Settings–Focus on Sub-Saharan Africa PhD thesis, University of Zurich, 2019.
16
GBD 2017 Causes of Death Collaborators: Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet392: 1736–1788, 201810.1016/s0140-6736(18)32203-7PubMed
GBD 2017 Causes of Death Collaborators: Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 392: 1736–1788, 201810.1016/s0140-6736(18)32203-7PubMed)| false
Garcia-GarciaG, JhaV; World Kidney Day Steering Committee: CKD in disadvantaged populations. Kidney Int87: 251–253, 201510.1038/ki.2014.369PubMed
Garcia-GarciaG, JhaV; World Kidney Day Steering Committee: CKD in disadvantaged populations. Kidney Int 87: 251–253, 201510.1038/ki.2014.369PubMed)| false
LuyckxVA, TonelliM, StaniferJW: The global burden of kidney disease and the sustainable development goals. Bull World Health Organ96: 414–422D, 201810.2471/BLT.17.206441PubMed
LuyckxVA, TonelliM, StaniferJW: The global burden of kidney disease and the sustainable development goals. Bull World Health Organ 96: 414–422D, 201810.2471/BLT.17.206441PubMed)| false
LuyckxVA, Al-AlyZ, BelloAK, Bellorin-FontE, CarliniRG, FabianJ, et al.: Sustainable Development Goals relevant to kidney health: An update on progress. Nat Rev Nephrol17: 15–32, 202110.1038/s41581-020-00363-6PubMed
LuyckxVA, Al-AlyZ, BelloAK, Bellorin-FontE, CarliniRG, FabianJ, : Sustainable Development Goals relevant to kidney health: An update on progress. Nat Rev Nephrol 17: 15–32, 202110.1038/s41581-020-00363-6PubMed)| false
NishtarS, NiinistöS, SirisenaM, VázquezT, SkvortsovaV, RubinsteinA, et al.; Commissioners of the WHO Independent High-Level Commission on NCDs: Time to deliver: Report of the WHO Independent High-Level Commission on NCDs. Lancet392: 245–252, 201810.1016/S0140-6736(18)31258-3PubMed
NishtarS, NiinistöS, SirisenaM, VázquezT, SkvortsovaV, RubinsteinA, ; Commissioners of the WHO Independent High-Level Commission on NCDs: Time to deliver: Report of the WHO Independent High-Level Commission on NCDs. Lancet 392: 245–252, 201810.1016/S0140-6736(18)31258-3PubMed)| false
World Health Organization: Global Action Plan for the prevention and control of noncommunicable diseases 2013-2020. Available at: http://www.who.int/nmh/events/ncd_action_plan/en/. Accessed April 30, 2021
LuyckxVA: Equity is key to build back better after COVID-19: Prioritize noncommunicable diseases and kidney health. Kidney3602: 747–750, 202110.34067/KID.0006932020PubMed
LuyckxVA: Equity is key to build back better after COVID-19: Prioritize noncommunicable diseases and kidney health. Kidney360 2: 747–750, 202110.34067/KID.0006932020PubMed)| false
ForemanKJ, MarquezN, DolgertA, FukutakiK, FullmanN, McGaugheyM, et al.: Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet392: 2052–2090, 201810.1016/s0140-6736(18)31694-5PubMed
ForemanKJ, MarquezN, DolgertA, FukutakiK, FullmanN, McGaugheyM, : Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet 392: 2052–2090, 201810.1016/s0140-6736(18)31694-5PubMed)| false
ThomasLM, D’AmbruosoL, BalabanovaD: Verbal autopsy in health policy and systems: A literature review. BMJ Glob Health3: e000639, 201810.1136/bmjgh-2017-000639PubMed
ThomasLM, D’AmbruosoL, BalabanovaD: Verbal autopsy in health policy and systems: A literature review. BMJ Glob Health 3: e000639, 201810.1136/bmjgh-2017-000639PubMed)| false
TonelliM, DickinsonJA: Early detection of CKD: Implications for low-income, middle-income, and high-income countries. J Am Soc Nephrol31: 1931–1940, 202010.1681/ASN.2020030277PubMed
TonelliM, DickinsonJA: Early detection of CKD: Implications for low-income, middle-income, and high-income countries. J Am Soc Nephrol 31: 1931–1940, 202010.1681/ASN.2020030277PubMed)| false
HtayH, AlrukhaimiM, AshuntantangGE, BelloAK, Bellorin-FontE, Benghanem GharbiM, et al.: Global access of patients with kidney disease to health technologies and medications: Findings from the Global Kidney Health Atlas project. Kidney Int Suppl (2011)8: 64–73, 201810.1016/j.kisu.2017.10.010
HtayH, AlrukhaimiM, AshuntantangGE, BelloAK, Bellorin-FontE, Benghanem GharbiM, : Global access of patients with kidney disease to health technologies and medications: Findings from the Global Kidney Health Atlas project. Kidney Int Suppl (2011) 8: 64–73, 201810.1016/j.kisu.2017.10.010)| false
Bernabé-OrtizA, Zafra-TanakaJH, Moscoso-PorrasM, SampathR, VetterB, MirandaJJ, et al.: Diagnostics and monitoring tools for noncommunicable diseases: A missing component in the global response. Global Health17: 26, 202110.1186/s12992-021-00676-6PubMed
Bernabé-OrtizA, Zafra-TanakaJH, Moscoso-PorrasM, SampathR, VetterB, MirandaJJ, : Diagnostics and monitoring tools for noncommunicable diseases: A missing component in the global response. Global Health 17: 26, 202110.1186/s12992-021-00676-6PubMed)| false
Velazquez BerumenA, GarnerS, HillSR, SwaminathanS: Making diagnostic tests as essential as medicines. BMJ Glob Health3: e001033, 201810.1136/bmjgh-2018-001033PubMed
Velazquez BerumenA, GarnerS, HillSR, SwaminathanS: Making diagnostic tests as essential as medicines. BMJ Glob Health 3: e001033, 201810.1136/bmjgh-2018-001033PubMed)| false
LevinA, TonelliM, BonventreJ, CoreshJ, DonnerJA, FogoAB, et al.; ISN Global Kidney Health Summit participants: Global kidney health 2017 and beyond: A roadmap for closing gaps in care, research, and policy. Lancet390: 1888–1917, 201710.1016/S0140-6736(17)30788-2PubMed
LevinA, TonelliM, BonventreJ, CoreshJ, DonnerJA, FogoAB, ; ISN Global Kidney Health Summit participants: Global kidney health 2017 and beyond: A roadmap for closing gaps in care, research, and policy. Lancet 390: 1888–1917, 201710.1016/S0140-6736(17)30788-2PubMed)| false
VanholderR, AnnemansL, BrownE, GansevoortR, Gout-ZwartJJ, LameireN, et al.; European Kidney Health Alliance: Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol13: 393–409, 201710.1038/nrneph.2017.63PubMed
VanholderR, AnnemansL, BrownE, GansevoortR, Gout-ZwartJJ, LameireN, ; European Kidney Health Alliance: Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol 13: 393–409, 201710.1038/nrneph.2017.63PubMed)| false
WirtzVJ, HogerzeilHV, GrayAL, BigdeliM, de JoncheereCP, EwenMA, et al.: Essential medicines for universal health coverage. Lancet389: 403–476, 201710.1016/S0140-6736(16)31599-9PubMed
WirtzVJ, HogerzeilHV, GrayAL, BigdeliM, de JoncheereCP, EwenMA, : Essential medicines for universal health coverage. Lancet 389: 403–476, 201710.1016/S0140-6736(16)31599-9PubMed)| false
ChowCK, NguyenTN, MarschnerS, DiazR, RahmanO, AvezumA, et al.; PURE Study: Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries. BMJ Glob Health5: e002640, 202010.1136/bmjgh-2020-002640PubMed
ChowCK, NguyenTN, MarschnerS, DiazR, RahmanO, AvezumA, ; PURE Study: Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries. BMJ Glob Health 5: e002640, 202010.1136/bmjgh-2020-002640PubMed)| false
KhatibR, McKeeM, ShannonH, ChowC, RangarajanS, TeoK, et al.; PURE study investigators: Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: An analysis of the PURE study data. Lancet387: 61–69, 201610.1016/S0140-6736(15)00469-9PubMed
KhatibR, McKeeM, ShannonH, ChowC, RangarajanS, TeoK, ; PURE study investigators: Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: An analysis of the PURE study data. Lancet 387: 61–69, 201610.1016/S0140-6736(15)00469-9PubMed)| false
EssueBM, et al.: Disease Control Priorities. Improving Health and Reducing Poverty, edited by JamisonDT, et al., Vol. 9, Washington, DC, World Bank, 2018, pp 121–143
EssueBM, : Disease Control Priorities. Improving Health and Reducing Poverty, edited by JamisonDT, et al., Vol. 9, Washington, DC, World Bank, 2018, pp 121–143)| false
EssueBM, WongG, ChapmanJ, LiQ, JanS: How are patients managing with the costs of care for chronic kidney disease in Australia? A cross-sectional study. BMC Nephrol14: 5, 201310.1186/1471-2369-14-5PubMed
EssueBM, WongG, ChapmanJ, LiQ, JanS: How are patients managing with the costs of care for chronic kidney disease in Australia? A cross-sectional study. BMC Nephrol 14: 5, 201310.1186/1471-2369-14-5PubMed)| false
KrukME, GageAD, JosephNT, DanaeiG, García-SaisóS, SalomonJA: Mortality due to low-quality health systems in the universal health coverage era: A systematic analysis of amenable deaths in 137 countries. Lancet392: 2203–2212, 201810.1016/s0140-6736(18)31668-4PubMed
KrukME, GageAD, JosephNT, DanaeiG, García-SaisóS, SalomonJA: Mortality due to low-quality health systems in the universal health coverage era: A systematic analysis of amenable deaths in 137 countries. Lancet 392: 2203–2212, 201810.1016/s0140-6736(18)31668-4PubMed)| false
KrukME, GageAD, ArsenaultC, JordanK, LeslieHH, Roder-DeWanS, et al.: High-quality health systems in the Sustainable Development Goals era: Time for a revolution. Lancet Glob Health6: e1196–e1252, 201810.1016/S2214-109X(18)30386-3PubMed
KrukME, GageAD, ArsenaultC, JordanK, LeslieHH, Roder-DeWanS, : High-quality health systems in the Sustainable Development Goals era: Time for a revolution. Lancet Glob Health 6: e1196–e1252, 201810.1016/S2214-109X(18)30386-3PubMed)| false
VanholderR, AnnemansL, BelloAK, BikbovB, GallegoD, GansevoortRT, et al.: Fighting the unbearable lightness of neglecting kidney health: The decade of the kidney. Clin Kidney J14: 1719–1730, 202110.1093/ckj/sfab070PubMed
VanholderR, AnnemansL, BelloAK, BikbovB, GallegoD, GansevoortRT, : Fighting the unbearable lightness of neglecting kidney health: The decade of the kidney. Clin Kidney J 14: 1719–1730, 202110.1093/ckj/sfab070PubMed)| false
BignallONR2nd, CrewsDC: Stony the road we trod: Towards racial justice in kidney care. Nat Rev Nephrol17: 79–80, 202110.1038/s41581-020-00389-wPubMed
BignallONR2nd, CrewsDC: Stony the road we trod: Towards racial justice in kidney care. Nat Rev Nephrol 17: 79–80, 202110.1038/s41581-020-00389-wPubMed)| false
Kevin TuckerJ: Social justice as a tool to eliminate inequities in kidney disease. Semin Nephrol 41: 203–210, 202110.1016/j.semnephrol.2021.05.001PubMed)| false
ERA-EDTA Council; ERACODA Working Group: Chronic kidney disease is a key risk factor for severe COVID-19: A call to action by the ERA-EDTA. Nephrol Dial Transplant36: 87–94, 202110.1093/ndt/gfaa314PubMed
ERA-EDTA Council; ERACODA Working Group: Chronic kidney disease is a key risk factor for severe COVID-19: A call to action by the ERA-EDTA. Nephrol Dial Transplant 36: 87–94, 202110.1093/ndt/gfaa314PubMed)| false
